Developer docs
API playgroundTry for free, no card

Search company profiles

Regents of the University of California

Full company profile

uuid00061gv

Namestring
Regents of the University of California
Legal namestring
Regents of the University of California
Company typeenum
Private
Founded yearint
1868
Descriptiontext

The Regents of the University of California is the constitutional governing board of the University of California system, headquartered at 1111 Franklin Street in Oakland, California. Founded in 1868, the Regents provide fiduciary, governance, and policy oversight for a public research enterprise that spans ten campuses (Berkeley, Davis, Irvine, UCLA, Riverside, San Diego, San Francisco, Santa Barbara, Santa Cruz, and Merced), three national laboratories (Lawrence Berkeley, Lawrence Livermore, and Los Alamos), and the UC Health system. Its core "products" are not commercial goods but academic instruction, scientific research, and public service functions delivered to undergraduate and graduate students, faculty and researchers, patients, and California residents.

The Regents' primary ongoing activities include setting tuition and policy, authorizing major capital projects, issuing tax-exempt debt, and stewarding the system's innovation and technology-transfer pipeline. In 2025 the Regents launched the UC Regents Innovation Awards — five award categories (Gamechanger, Disruptive Research, Best Startup, Community Changemaker, Distinguished Lifetime Achievement) with minimum $10,000 prizes — to formalize the path from academic research to commercialized products and startups. The Board also authorized a 300,000-square-foot oncology and incubator laboratory facility in San Francisco's Dogpatch Power Station district as a public-private partnership, with construction beginning August 26, 2025 and a planned 2029 opening featuring next-generation proton beam therapy. The Regents additionally acts as a corporate investor, having participated in Sprinter Health's $55 million Series B in June 2025.

The Regents' revenue base is composed of state appropriations, tuition and fees, federal research grants (notably from the US Department of Energy to the three managed national laboratories), patient-care revenue through UC Health, donor and endowment returns, and tax-exempt bond proceeds; no commercial pricing model is published in the input, consistent with its status as a public entity. Customer segments are students, faculty/researchers, healthcare consumers (including oncology patients), and indirectly California taxpayers and policymakers who fund the system. Its partnership posture is anchored by major capital P3 transactions (Norton Rose Fulbright as legal advisor to the Dogpatch deal) and selective venture participation alongside tier-one investors such as General Catalyst, Andreessen Horowitz, Google Ventures, and Accel.

Short descriptiontext

The Regents of the University of California is the constitutional governing board of a public research university system, overseeing ten campuses, three national laboratories, and UC Health to deliver education, research, healthcare, and innovation services to students, faculty, patients, and the public across California.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersOakland, United States
HQ citystring
Oakland
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
public university system, higher education services, scientific research, academic instruction, university governance
Industry4 codes
1Public Research Universities with Multi-Campus Systems
CodeEDAHAAAIPrimaryYes
2Public Research Universities with National Laboratories/Big Science Facilities
CodeEDAHAAAJPrimaryNo
3Public Research Universities with Comprehensive Graduate & Professional Schools
CodeEDAHAAAFPrimaryNo
4Academic Affairs Administration (Curriculum, Scheduling, Academic Policy)
CodeEDADAKABPrimaryNo
NAICS code2 codes
  • Colleges, Universities, and Professional Schools6113
  • Colleges, Universities, and Professional Schools611310
Product category
Public Higher Education and Research
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Infrastructure, Technology or R&D, Operations, Others
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

The Regents of the University of California is the governing board of the University of California, a public research university system that operates ten campuses and three national laboratories. Its core offerings encompass higher education instruction (undergraduate, graduate, and professional degree programs), use-inspired scientific research across multiple disciplines, public service, and patient healthcare delivered through UC health systems. The Board of Regents also administers an innovation awards program to recognize faculty and researchers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 300,000 sq ft oncology facility with next-generation proton beam therapy, opening 2029
Product overview1 text field

The UC Regents Innovation Awards is a single, unified awards recognition program offered by the Board of Regents. It encompasses five distinct award categories designed to recognize use-inspired research, civically-responsible entrepreneurship, and the translation of academic research into practical solutions with societal benefit. The program accepts nominations annually from UC's ten campuses and three national laboratories, with monetary prizes of at least $10,000 for winners of the Gamechanger, Disruptive Research, and Best Startup awards.

Product and service1 record
1UC Regents Innovation Awards Program
CategoryUniversity Innovation Program
Description

A recognition program offered by the Board of Regents to celebrate UC faculty and researchers who demonstrate exceptional innovation through creation of new technologies, products, and services, with five award categories (Gamechanger, Disruptive Research, Best Startup, Community Changemaker, Distinguished Lifetime Achievement) and monetary prizes of at least $10,000 for winners.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2025-08-26
Description

Norton Rose Fulbright served as legal advisor to The Regents of the University of California on a major public-private partnership (P3) transaction to develop a 300,000 square foot oncology and incubator laboratory facility in San Francisco's Dogpatch Power Station district.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

The UCSF oncology and incubator laboratory facility serves as the anchor tenant for the Dogpatch Power Station district redevelopment project in San Francisco. The project includes a cancer treatment center with next-generation proton beam therapy, research laboratories, and multi-specialty clinical space.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

The other California public higher education system — 23 campuses serving undergraduate and graduate students with public funding and Board governance. Directly comparable as a multi-campus public California university system competing for state appropriations and overlapping student populations, though positioned more on teaching and access versus UC's research focus.

TypeRegional player
Description

New York's multi-campus public university system with university centers, state colleges, and community colleges, governed by a Board of Trustees. Comparable in scale and structure to UC (multi-campus, public, research-and-teaching mix), but operating in a different state with distinct funding and policy environment.

TypeRegional player
Description

Governing body for eight public universities and six health institutions in Texas, including UT Austin and multiple health science centers. Comparable as a multi-campus state public university system with significant research output, healthcare delivery, and constitutional/state-chartered governance.

TypeRegional player
Description

Multi-campus public university system in Wisconsin comprising 13 universities governed by a single Board of Regents. Comparable as a public, multi-campus state university system with research flagship (UW-Madison) and statewide teaching footprint analogous to UC's structure.

TypeRegional player
Description

A multi-campus public research university system with a unified Board of Trustees, a research-intensive flagship, and 20+ Commonwealth Campuses across Pennsylvania. Comparable to UC in offering both research-led and broad-access undergraduate education under a single governing body with significant athletics and donor revenue.

TypeRegional player
Description

Urban public university system in New York City with 25 campuses and a single Board of Trustees. Comparable to UC as a large, multi-campus public system serving diverse student populations with both research and teaching mandates, though operating primarily in a single metropolitan market.

TypeRegional player
Description

Top-ranked public research university (single flagship) with a major academic medical center and substantial federal research funding. Comparable to individual UC campuses (e.g., Berkeley, UCLA) as a flagship public research institution, but does not have UC's multi-campus governance and national lab mandate.

TypeRegional player
Description

Premier private research university located in California, with a major medical center, strong engineering school, and active technology-transfer ecosystem. Comparable to UC as a California-based research and healthcare competitor for talent and students, but privately endowed and single-campus versus UC's public multi-campus system.

TypeBroad incumbent
Description

The U.S.'s largest endowment and most recognized private research university, with extensive medical, law, and business schools plus affiliated hospitals. Comparable to UC at the institutional-research-product level (instruction, research, healthcare), but operates as a single private institution with no equivalent statewide governance or national lab role.

TypeBroad incumbent
Description

Elite private research university with leading engineering, science, and computer science programs plus a major technology-transfer and venture ecosystem. Comparable to UC in research intensity and innovation output, but operates as a single private institution with concentrated research funding rather than UC's distributed public multi-campus model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights4 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment5 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Regents of the University of California

Public Higher Education and Researchregents.universityofcalifornia.edu

The Regents of the University of California is the constitutional governing board of a public research university system, overseeing ten campuses, three national laboratories, and UC Health to deliver education, research, healthcare, and innovation services to students, faculty, patients, and the public across California.

What Regents of the University of California does

The Regents of the University of California is the constitutional governing board of the University of California system, headquartered at 1111 Franklin Street in Oakland, California. Founded in 1868, the Regents provide fiduciary, governance, and policy oversight for a public research enterprise that spans ten campuses (Berkeley, Davis, Irvine, UCLA, Riverside, San Diego, San Francisco, Santa Barbara, Santa Cruz, and Merced), three national laboratories (Lawrence Berkeley, Lawrence Livermore, and Los Alamos), and the UC Health system. Its core "products" are not commercial goods but academic instruction, scientific research, and public service functions delivered to undergraduate and graduate students, faculty and researchers, patients, and California residents.

The Regents' primary ongoing activities include setting tuition and policy, authorizing major capital projects, issuing tax-exempt debt, and stewarding the system's innovation and technology-transfer pipeline. In 2025 the Regents launched the UC Regents Innovation Awards — five award categories (Gamechanger, Disruptive Research, Best Startup, Community Changemaker, Distinguished Lifetime Achievement) with minimum $10,000 prizes — to formalize the path from academic research to commercialized products and startups. The Board also authorized a 300,000-square-foot oncology and incubator laboratory facility in San Francisco's Dogpatch Power Station district as a public-private partnership, with construction beginning August 26, 2025 and a planned 2029 opening featuring next-generation proton beam therapy. The Regents additionally acts as a corporate investor, having participated in Sprinter Health's $55 million Series B in June 2025.

The Regents' revenue base is composed of state appropriations, tuition and fees, federal research grants (notably from the US Department of Energy to the three managed national laboratories), patient-care revenue through UC Health, donor and endowment returns, and tax-exempt bond proceeds; no commercial pricing model is published in the input, consistent with its status as a public entity. Customer segments are students, faculty/researchers, healthcare consumers (including oncology patients), and indirectly California taxpayers and policymakers who fund the system. Its partnership posture is anchored by major capital P3 transactions (Norton Rose Fulbright as legal advisor to the Dogpatch deal) and selective venture participation alongside tier-one investors such as General Catalyst, Andreessen Horowitz, Google Ventures, and Accel.

Regents of the University of California firmographics

Firmographics
Name
Regents of the University of California
Legal name
Regents of the University of California
Website
https://regents.universityofcalifornia.edu
Company type
Private
Founded year
1868
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
The Regents of the University of California is the constitutional governing board of a public research university system, overseeing ten campuses, three national laboratories, and UC Health to deliver education, research, healthcare, and innovation services to students, faculty, patients, and the public across California.
Ownership category
akta.pro rank

Regents of the University of California industry classification

Industry
Product category
Public Higher Education and Research
NAICS
Colleges, Universities, and Professional Schools (6113), Colleges, Universities, and Professional Schools (611310)
akta.pro primary industry
Public Research Universities with Multi-Campus Systems (EDAHAAAI)
akta.pro secondary industries
Public Research Universities with National Laboratories/Big Science Facilities (EDAHAAAJ), Public Research Universities with Comprehensive Graduate & Professional Schools (EDAHAAAF), Academic Affairs Administration (Curriculum, Scheduling, Academic Policy) (EDADAKAB)

Keywords

  • Public university system
  • Higher education services
  • Scientific research
  • Academic instruction
  • University governance

Where Regents of the University of California is headquartered

Location

Headquarters

HQ city
Oakland
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Regents of the University of California business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Infrastructure, Technology or R&D, Operations, Others

Distribution channels3 records

Marketing channels4 records

Regents of the University of California product offering

Product offering

Core offering

The Regents of the University of California is the governing board of the University of California, a public research university system that operates ten campuses and three national laboratories. Its core offerings encompass higher education instruction (undergraduate, graduate, and professional degree programs), use-inspired scientific research across multiple disciplines, public service, and patient healthcare delivered through UC health systems. The Board of Regents also administers an innovation awards program to recognize faculty and researchers.

Product overview

The UC Regents Innovation Awards is a single, unified awards recognition program offered by the Board of Regents. It encompasses five distinct award categories designed to recognize use-inspired research, civically-responsible entrepreneurship, and the translation of academic research into practical solutions with societal benefit. The program accepts nominations annually from UC's ten campuses and three national laboratories, with monetary prizes of at least $10,000 for winners of the Gamechanger, Disruptive Research, and Best Startup awards.

Differentiator

Problem solved

Functional benefit

Products and services

  • UC Regents Innovation Awards Program A recognition program offered by the Board of Regents to celebrate UC faculty and researchers who demonstrate exceptional innovation through creation of new technologies, products, and services, with five award categories (Gamechanger, Disruptive Research, Best Startup, Community Changemaker, Distinguished Lifetime Achievement) and monetary prizes of at least $10,000 for winners.

Quantifiable outcome

  • 300,000 sq ft oncology facility with next-generation proton beam therapy, opening 2029

Companies that use Regents of the University of California

Customer profile

Segments4 records

Ideal customer profiles3 records

Regents of the University of California technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Regents of the University of California partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered major.

  • Norton Rose FulbrightmajorStrategic or Co-development Partner · 26 August 2025Norton Rose Fulbright served as legal advisor to The Regents of the University of California on a major public-private partnership (P3) transaction to develop a 300,000 square foot oncology and incubator laboratory facility in San Francisco's Dogpatch Power Station district.
  • Dogpatch Power Station district redevelopmentmajorStrategic or Co-development PartnerThe UCSF oncology and incubator laboratory facility serves as the anchor tenant for the Dogpatch Power Station district redevelopment project in San Francisco. The project includes a cancer treatment center with next-generation proton beam therapy, research laboratories, and multi-specialty clinical space.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Regents of the University of California competitors and assessment

Company assessment

Direct peers

  • California State University (CSU): The other California public higher education system — 23 campuses serving undergraduate and graduate students with public funding and Board governance. Directly comparable as a multi-campus public California university system competing for state appropriations and overlapping student populations, though positioned more on teaching and access versus UC's research focus.

Regional players

  • State University of New York (SUNY): New York's multi-campus public university system with university centers, state colleges, and community colleges, governed by a Board of Trustees. Comparable in scale and structure to UC (multi-campus, public, research-and-teaching mix), but operating in a different state with distinct funding and policy environment.
  • University of Texas System: Governing body for eight public universities and six health institutions in Texas, including UT Austin and multiple health science centers. Comparable as a multi-campus state public university system with significant research output, healthcare delivery, and constitutional/state-chartered governance.
  • University of Wisconsin System: Multi-campus public university system in Wisconsin comprising 13 universities governed by a single Board of Regents. Comparable as a public, multi-campus state university system with research flagship (UW-Madison) and statewide teaching footprint analogous to UC's structure.
  • Pennsylvania State University (Penn State): A multi-campus public research university system with a unified Board of Trustees, a research-intensive flagship, and 20+ Commonwealth Campuses across Pennsylvania. Comparable to UC in offering both research-led and broad-access undergraduate education under a single governing body with significant athletics and donor revenue.
  • City University of New York (CUNY): Urban public university system in New York City with 25 campuses and a single Board of Trustees. Comparable to UC as a large, multi-campus public system serving diverse student populations with both research and teaching mandates, though operating primarily in a single metropolitan market.
  • University of Michigan: Top-ranked public research university (single flagship) with a major academic medical center and substantial federal research funding. Comparable to individual UC campuses (e.g., Berkeley, UCLA) as a flagship public research institution, but does not have UC's multi-campus governance and national lab mandate.
  • Stanford University: Premier private research university located in California, with a major medical center, strong engineering school, and active technology-transfer ecosystem. Comparable to UC as a California-based research and healthcare competitor for talent and students, but privately endowed and single-campus versus UC's public multi-campus system.

Broad incumbents

  • Harvard University: The U.S.'s largest endowment and most recognized private research university, with extensive medical, law, and business schools plus affiliated hospitals. Comparable to UC at the institutional-research-product level (instruction, research, healthcare), but operates as a single private institution with no equivalent statewide governance or national lab role.
  • Massachusetts Institute of Technology (MIT): Elite private research university with leading engineering, science, and computer science programs plus a major technology-transfer and venture ecosystem. Comparable to UC in research intensity and innovation output, but operates as a single private institution with concentrated research funding rather than UC's distributed public multi-campus model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights4 records

Customer concentration

Regents of the University of California social profiles

Digital presence

Regents of the University of California financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Regents of the University of California leadership team

Management profile

Number of profiles

Profiles5 records

Regents of the University of California funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Regents of the University of California M&A and investment

M&A and investment

M&A

Investments5 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Regents of the University of California

What does Regents of the University of California do?

The Regents of the University of California is the governing board of the University of California, a public research university system that operates ten campuses and three national laboratories. Its core offerings encompass higher education instruction (undergraduate, graduate, and professional degree programs), use-inspired scientific research across multiple disciplines, public service, and patient healthcare delivered through UC health systems. The Board of Regents also administers an innovation awards program to recognize faculty and researchers.

Is Regents of the University of California a public or private company?

Regents of the University of California is a private company. It is classified as state government owned and is currently operating.

When was Regents of the University of California founded?

Regents of the University of California was founded in 1868. It employs 5,001 to 10,000 people.

Where is Regents of the University of California based?

Regents of the University of California is headquartered in Oakland, United States, in the North America region.

Who are Regents of the University of California's main competitors?

California State University (CSU) is listed as a direct peer. Regional players are State University of New York (SUNY), University of Texas System, University of Wisconsin System, Pennsylvania State University (Penn State), City University of New York (CUNY), University of Michigan and Stanford University. Broad incumbents are Harvard University and Massachusetts Institute of Technology (MIT).

Does Regents of the University of California have an API?

No public API is recorded for Regents of the University of California.

What industry is Regents of the University of California in?

Regents of the University of California's product category is Public Higher Education and Research. Its primary akta.pro industry code is EDAHAAAI, Public Research Universities with Multi-Campus Systems, with a secondary code of EDAHAAAJ, Public Research Universities with National Laboratories/Big Science Facilities. Its NAICS code is 6113.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Los Angeles Times‘Revenge of the Nerds’ star Robert Carradine’s family sues UCLA over his deathThe family of actor Robert Carradine filed a wrongful-death lawsuit against the University of California Regents and UCLA Health, alleging that his suicide at a university-affiliated psychiatric facility was preventable due to reckless care and neglect. The complaint claims staff failed to follow safety protocols, such as removing potential ligature hazards and maintaining required observation intervals, leading to his death approximately 19 hours after admission.Wide Open CountryFamily of Actor Who Died by Suicide Files Wrongful Death LawsuitThe family of actor Robert Carradine has filed a wrongful death lawsuit against the Regents of the University of California, alleging that staff at UCLA’s Resnick Neuropsychiatric Hospital committed elder abuse and neglect leading to his suicide. The suit claims hospital staff violated safety protocols by allowing Carradine into a locked unit with a belt and failing to perform required 15-minute checks. The family is seeking damages for wrongful death and emotional distress while highlighting issues in mental health care.PatsnapAragon & Janssen v. Hetero Labs — Apalutamide (Erleada®) Patent Litigation | PatSnapAragon Pharmaceuticals, Janssen Biotech, and the Regents of the University of California obtained a consent judgment against Hetero Labs and Hetero USA in the District of New Jersey, blocking generic apalutamide (Erleada®) from the US market until expiry of three asserted patents covering the prostate cancer therapy. Hetero expressly admitted the validity and infringement of patents US9987261B2, US8802689B2, and US9388159B2, waived all appellate rights, and agreed to a permanent injunction covering its affiliates and all forms of US commercialization. The case resolved in 131 days — well before the standard 30-month Hatch-Waxman stay expired — with each party bearing its own costs.JD SupraParties File Supplemental Priority Statements in CRISPR InterferenceBroad Institute, Harvard, and MIT (Broad) and the Regents of the University of California, University of Vienna, and Emmanuelle Charpentier (CVC) each filed supplemental priority statements in Patent Interference No. 106,115 before the PTAB, with both parties asserting earlier conception dates for CRISPR-Cas9 gene editing technology using single guide RNA (sgRNA). Broad claimed conception as early as August 2011 through a vector design and January 2012 NIH grant proposal, while CVC asserted conception dates of March 1, April 11, May 28, or June 28, 2012, with opening briefs due October 10, 2025. The Federal Circuit vacated and remanded the Board's prior decision that had awarded priority to Broad, making this a critical proceeding for determining who holds foundational patents on CRISPR-Cas9 technology.JD SupraMeanwhile, Back at the PTAB with CRISPR – UpdateThe PTAB held a conference call on August 15, 2025, to address procedural matters following the Federal Circuit's remand of Interference No. 106,115 involving the CRISPR patent dispute between the Broad Institute/Harvard/MIT (Senior Party) and the University of California Berkeley/University of Vienna/Emmanuelle Charpentier (Junior Party). The Board issued an order establishing a briefing schedule where both parties must submit supplemental priority statements by October 10, 2025, with responses due November 7 and replies by December 5, 2025, while also replacing two of three Administrative Patent Judges on the panel.White & Case LLPFederal Circuit clarifies standard for patent conception in ongoing CRISPR disputeThe U.S. Court of Appeals for the Federal Circuit vacated and remanded a Patent Trial and Appeal Board decision in the ongoing patent priority dispute between the Regents of the University of California and the Broad Institute regarding CRISPR-Cas9 patents. The court ruled that the PTAB erred by requiring inventors to prove their invention would work to establish conception, clarifying the legal standard for patent priority under the pre-AIA system. This ruling opens the possibility for the Regents to gain priority, with further proceedings expected at the PTAB.GlobeNewswirePacific Software Inc. Secures Strategic License Agreement with the University of California for Innovative Technology for Stimulating Collagen ProductionPacific Software Inc. secured an exclusive licensing agreement with the University of California Regents for peptide inhibitors of insulin-degrading enzyme, developed at UCI. The company will become an equity partner, and the technology, marketed as Dermatrix, is confirmed to stimulate collagen production in peer-reviewed experiments.PR NewswireGBW Attorneys Obtain Groundbreaking $39 Million Jury Verdict Against the Regents of The University of California for Doctor's Whistleblower RetaliationA San Diego jury awarded Dr. Kevin Murphy more than $39 million in damages on August 2, 2023, finding that UC San Diego retaliated against him for whistleblowing about the university diverting a $10 million donation intended for his research to the Moores Cancer Center without his consent. The jury awarded approximately $10 million in economic damages and $30 million in emotional distress damages, while the Regents of the University of California received only $67,000 on their counterclaim for breach of duty of loyalty. Dr. Murphy's PrTMS brain stimulation therapy, which was the subject of the disputed donation, has shown promise in treating depression, PTSD, autism, and concussions.PR NewswirePattern Energy Signs Power Purchase Agreements for Largest Wind Project in U.S. HistoryPattern Energy Group LP has signed long-term Power Purchase Agreements with Shell Energy North America and the Regents of the University of California for power from its 3,500+ MW SunZia Wind project in New Mexico, which the company describes as the largest wind project in U.S. history. Construction is expected to begin later in 2023 with completion targeted for 2026, when the project will deliver power to western energy markets via the SunZia Transmission HVDC line connecting central New Mexico to Arizona. An independent study estimates the combined SunZia Wind and Transmission projects will generate $20.5 billion in total economic benefit and $1.3 billion in fiscal impacts for governments, communities, and schools.BenzingaIzotropic Unveils Izoview Commercial Prototype, Files New PatentsIzotropic Corporation unveiled the commercial prototype design of its IzoView dedicated breast CT imaging platform, which will be used in forthcoming clinical studies for U.S. market authorization. The device features self-shielding technology that contains radiation within the machine, protecting operators and eliminating the need for conventional protective barriers. The company has filed new patents co-owned with The Regents of the University of California, from which it holds exclusive worldwide licensing rights to Breast CT technology.